DETERMARX
Live / Registered — Registered (as of 11 May 2021)
What this means for you
Registered since 11 May 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88980839
- Registration number
- 6350018
- Mark type
- Stylized text
- Filed
- 06 Nov 2019
- Published for opposition
- 02 Jun 2020
- Registered
- 11 May 2021
- Attorney of record
- Christopher D. Olszyk, Jr.
Goods and services
- Class 042 — Scientific and technological services: Providing reagent sample testing and diagnostic services for others in the field of cancer testing, tumor testing, and screening for the purpose of evaluating risk factors, the probability of cancer reoccurrence, and need for subsequent therapeutic treatment
Owner
- OncoCyte Corporation, Irvine, CA, US
- OncoCyte Corporation, Irvine, CA, US
- OncoCyte Corporation, Alameda, CA, US
Prosecution history
- 11 May 2021 — REGISTERED-PRINCIPAL REGISTER
- 09 Apr 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Apr 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Mar 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Jan 2021 — USE AMENDMENT FILED
- 09 Mar 2021 — DIVISIONAL PROCESSING COMPLETE
- 07 Dec 2020 — DIVISIONAL REQUEST RECEIVED
- 16 Feb 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Jan 2021 — TEAS REQUEST TO DIVIDE RECEIVED
- 28 Jan 2021 — TEAS STATEMENT OF USE RECEIVED
- 28 Jul 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Jun 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 17 Jun 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Jun 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 02 Jun 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED